Tuberculosis Trial, Recruiting NCT07117370 Sponsor: Arizona State University Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT07117370
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

(Note: This trial has two parts — Aim 2 and Aim 3 — each with slightly different requirements)

For Aim 2:

  • You identify as a man
  • You are 18 years old or older
  • You are starting tuberculosis (TB) treatment for the first time, or restarting it after having stopped and lost contact with care, following South African national health guidelines
  • You live in the Buffalo City Metro (BCM) Health Districts area of South Africa
  • You are able and willing to sign a written consent form

For Aim 3:

  • You identify as a man
  • You are 18 years old or older
  • You are starting tuberculosis (TB) treatment for the first time, or restarting it after having stopped and lost contact with care, following South African national health guidelines
  • You are HIV-positive
  • You are not currently taking HIV treatment (antiretroviral therapy/ART)
  • You live in the Buffalo City Metro (BCM) Health Districts area of South Africa
  • You are able and willing to sign a written consent form

Who may not be able to join:

For Aim 2:

  • You do not identify as a man
  • You are under 18 years old
  • You are not starting or restarting TB treatment as described above
  • You do not live in the BCM Health Districts area
  • You are unable to sign a written consent form

For Aim 3:

  • You do not identify as a man
  • You are under 18 years old
  • You are not starting or restarting TB treatment as described above
  • You are not HIV-positive
  • You are currently taking HIV treatment (antiretroviral therapy/ART)
  • You do not live in the BCM Health Districts area
  • You are unable to sign a written consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 206-459-5777

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Arizona State University
Registry
ClinicalTrials.gov
Start date
1 June 2024
Est. completion
31 August 2026

Where this trial is recruiting

🇿🇦 South Africa

Primary endpoints

Intervention Feasibility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov